Review




Structured Review

Bio X Cell ctla 4 ig
Ctla 4 Ig, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla 4 ig/product/Bio X Cell
Average 94 stars, based on 15 article reviews
ctla 4 ig - by Bioz Stars, 2026-03
94/100 stars

Images



Similar Products

99
ATCC culture conditions adherent ctla 4 ig 24 cho cells
Culture Conditions Adherent Ctla 4 Ig 24 Cho Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/culture conditions adherent ctla 4 ig 24 cho cells/product/ATCC
Average 99 stars, based on 1 article reviews
culture conditions adherent ctla 4 ig 24 cho cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

94
Bio X Cell ctla 4 ig
Ctla 4 Ig, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla 4 ig/product/Bio X Cell
Average 94 stars, based on 1 article reviews
ctla 4 ig - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Clinisciences ctla-4 fusion protein (ctla-4 ig/ abatacept)
Ctla 4 Fusion Protein (Ctla 4 Ig/ Abatacept), supplied by Clinisciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla-4 fusion protein (ctla-4 ig/ abatacept)/product/Clinisciences
Average 90 stars, based on 1 article reviews
ctla-4 fusion protein (ctla-4 ig/ abatacept) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Bio X Cell invivomab recombinant ctla4 ig
(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of <t>CTLA4-Ig</t> plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .
Invivomab Recombinant Ctla4 Ig, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/invivomab recombinant ctla4 ig/product/Bio X Cell
Average 93 stars, based on 1 article reviews
invivomab recombinant ctla4 ig - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Revivicor inc gal ko. hcd46.ctla-4 ig transgenic pigs
(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of <t>CTLA4-Ig</t> plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .
Gal Ko. Hcd46.Ctla 4 Ig Transgenic Pigs, supplied by Revivicor inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gal ko. hcd46.ctla-4 ig transgenic pigs/product/Revivicor inc
Average 90 stars, based on 1 article reviews
gal ko. hcd46.ctla-4 ig transgenic pigs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bio X Cell ctla- 4 ig
(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of <t>CTLA4-Ig</t> plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .
Ctla 4 Ig, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla- 4 ig/product/Bio X Cell
Average 90 stars, based on 1 article reviews
ctla- 4 ig - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bio X Cell ctla-4 ig #be0099
(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of <t>CTLA4-Ig</t> plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .
Ctla 4 Ig #Be0099, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla-4 ig #be0099/product/Bio X Cell
Average 90 stars, based on 1 article reviews
ctla-4 ig #be0099 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bio X Cell invivomab recombinant ctla-4-ig
(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of <t>CTLA4-Ig</t> plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .
Invivomab Recombinant Ctla 4 Ig, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/invivomab recombinant ctla-4-ig/product/Bio X Cell
Average 90 stars, based on 1 article reviews
invivomab recombinant ctla-4-ig - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bristol Myers ctla-4-ig (abatacept
(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of <t>CTLA4-Ig</t> plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .
Ctla 4 Ig (Abatacept, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla-4-ig (abatacept/product/Bristol Myers
Average 90 stars, based on 1 article reviews
ctla-4-ig (abatacept - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Syd Labs ctla-4-ig fusion proteins
(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of <t>CTLA4-Ig</t> plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .
Ctla 4 Ig Fusion Proteins, supplied by Syd Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ctla-4-ig fusion proteins/product/Syd Labs
Average 90 stars, based on 1 article reviews
ctla-4-ig fusion proteins - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .

Journal: Cell reports

Article Title: Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling

doi: 10.1016/j.celrep.2024.114664

Figure Lengend Snippet: (A) Schematic of the experimental setup. (B) Determination of blood half-life time of 89 Zr-NB ( n = 5 mice/group). (C) Representative whole-body 2D positron emission tomography with computed tomography (PET/CT) image of a C57BL/6J mouse heterotopically transplanted with a BALB/c heart 24 h after injection of 89 Zr-NBs. (D) Gamma counting of organs from C57BL/6J mice heterotopically transplanted with a BALB/c heart 24 h after 89 Zr-NBs injection ( n = 5 mice/group). (E) Flow cytometry of DiO-NB uptake in bone marrow, spleen, and graft 24 h after DiO-NB administration ( n = 3 mice/group). (F) Kaplan-Meier curve with log-rank test for graft survival ( n = 6 mice/group). *** p < 0.001. (G) Leukocytes infiltrated in native hearts and allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated mice 100 days post-transplantation ( n = 6 mice). * p < 0.05, paired t test. (H) Immune cell subsets in allografts of CTLA4-Ig plus CD40-TRAF6i-NB-treated recipient mice 100 days post-transplantation ( n = 6 mice). Mean ± SEM are shown. See also and .

Article Snippet: InVivoMAb Recombinant CTLA4-Ig (for in vitro studies) , BioXcell , Cat#BE0099; RRID: AB_10949064.

Techniques: Positron Emission Tomography, Computed Tomography, Positron Emission Tomography-Computed Tomography, Injection, Flow Cytometry, Transplantation Assay

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling

doi: 10.1016/j.celrep.2024.114664

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: InVivoMAb Recombinant CTLA4-Ig (for in vitro studies) , BioXcell , Cat#BE0099; RRID: AB_10949064.

Techniques: Purification, Recombinant, In Vitro, Staining, Protease Inhibitor, In Vivo, Enzyme-linked Immunosorbent Assay, Cell Isolation, Isolation, CyQUANT Assay, LDH Cytotoxicity Assay, Chromatin Immunoprecipitation, Functional Assay, Software